Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: a 6 Months Prospective Study

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: a 6 Months Prospective Study

Background: Some patients experience statin-induced side effects or prefer nutraceutical approaches for the treatment of dyslipidemia. This has led to a search for alternative therapeutic approaches for dyslipidemia management. In recent studies Citrus bergamia (known as Bergamot) juice was able to...

Full description

Bibliographic Details
Main Authors: Peter P. eToth, Angelo Maria ePatti, Dragana eNikolic, Rosaria Vincenza eGiglio, Giuseppa eCastellino, Teresa eBiancucci, Fabiana eGeraci, Sabrina eDavid, Giuseppe eMontalto, Ali eRizvi, Manfredi eRizzo
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-01-01
Series:Frontiers in Pharmacology
Subjects:
Hypercholesterolemia
cardiovascular risk
Bergamot
LDL subclasses
Carotid IMT
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00299/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00299/full

Similar Items